Oct 2026
A pectic polysaccharide from Lonicera japonica alleviates DNCB-induced atopic dermatitis-like inflammation associated with gut microbial and metabolic alterations and reduced cutaneous JAK2/STAT3 activation and Th17 responses.
Findings indicate that oral WLJP-025p treatment is associated with concurrent intestinal and cutaneous changes in this AD-like model, and exerted protective effects against DNCB-induced AD-like dermatitis.
Ming-Zhu Jin, Yue-Feng Hu, M. Ding et al.
· Journal of Ethnopharmacology · 0 citations